Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel

BACKGROUND: Cabazitaxel improves overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients progressing after docetaxel. In this prospective study, we evaluated the prognostic role of CTC gene expression on cabazitaxel-treated patients and its association with plasma a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurioli, Giorgia, Conteduca, Vincenza, Brighi, Nicole, Scarpi, Emanuela, Basso, Umberto, Fornarini, Giuseppe, Mosca, Alessandra, Nicodemo, Maurizio, Banna, Giuseppe Luigi, Lolli, Cristian, Schepisi, Giuseppe, Ravaglia, Giorgia, Bondi, Isabella, Ulivi, Paola, De Giorgi, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805338/
https://www.ncbi.nlm.nih.gov/pubmed/35101049
http://dx.doi.org/10.1186/s12916-022-02244-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805338/
https://www.ncbi.nlm.nih.gov/pubmed/35101049
http://dx.doi.org/10.1186/s12916-022-02244-0

Ejemplares similares